"Anxiety over the two-day Fed policy meeting, centered on expectations the central bank will likely drop its pledge to keep interest rates low for a "considerable time," was a primary driver behind stocks snapping a five-week winning streak this week and bonds absorbing their steepest losses in at least two months."
PSEC seems to be moving down in sympathy with high divi stocks & the bond market.
I bought into NSPH because I felt their testing platform and benefits were the FUTURE of medical testing. There is no doubt that the Verigene system is valuable, the issue remains can management keep the company afloat until revenue takes off??? I am holding my shares even with a considerable loss at present. I think the slow down of placements and the drop in share price has people worried. They are thinking......" Should I sell and recover some of my investment..... or double down at these low prices?" If I knew the answer I would do just that. But it's anyone's guess as to the future of NSPH.
Selling out to a big Pharma ( or at least a large part of the company) is what is what needs to happen at this point in time. This would give them plenty of capital and the marketing clout of a big Pharma. If it does play out this way the shares at the current price are likely a bargain. If they do not do this they may have a hard time staying afloat and the shares will be worthless. JMHO
NSPH needs to find a large Pharma partner at this point. Maybe issue new shares & sell a major interest in the company for a cut of future profits. But this would keep them afloat ......... by giving them more $$$$ and the marketing clout of the Big Pharma.
Not imminent but I am sure they are marketing the company so they won't have to be in that position in the next quarter or two.
NSPH has great technology, enough money in the bank for 2 more quarters PLUS $30 mil more in the form of a line of credit ( 3 more quarters ). Management has finally realised they need either a Big Pharma partner .... or to sell the company. The company is in no way going BK right away & chances are there will be someone interested in buying them for their Verigene system. The question is at what price. JMHO.
Sorry $3.20 stock price minus $1.20 in cash means nothing about where HERO is trading. LOL. That would be true if they had no debt. You have to figure in debt too.
I do agree HERO is under valued at the current price due to their North Sea contract value. We may see lower prices before we base however. But buying at current levels is likely a good buy IF you are willing to hold it for a year or two. Insiders know it is priced cheap........ but they also know it may be a few quarters or more before the stock recovers.
NSPH is a developmental company working to take their technology prime time. Kodak, RCA and Control Data are companies that were leaders in their field for many years that did not change with technology fast enough and went out of business. Not a good comparison IMO.
NSPH has a promising technology and the question is can they monetise it before it is passed up by competitors with similar technology. They are moving slower than we would all like them to move obviously. So you either place your bets for survival or for failure. Keep in mind that betting on failure could be overridden by a buyout from a larger medical company for their technology. So either they go out of business, they succeed or are sold in the next 12 -24 months. PLACE YOUR BETS.
NSPH moved down because placements slowed down last quarter. However the next time something positive comes out we will see upward movement. The last time NSPH broke below $1 it went to $4. The fact is that you can make money in the stock without the company actually being profitable yet. Buying when bad news comes out gets a you a low price. When something good hits the wires it rises and you get a selling opportunity for a profit.
NSPH has a promising technology and they have enough money and financial backing to keep going for at least another 5 quarters and likely longer with additional stock placements. We will see the stock up & down many times in the next two years. Buy low sell high is the game. GLTA
One more thing.......... NSPH has plenty of cash lined up for operational expenses for the next 2 YEARS, they have a great new testing technology for the medical world that is getting adapted ( slower than we would all like ) , they have more tests pending with the FDA to add to their offering AND the stock is at a historic 6 year low price. Last time the stock dipped below $1 due to a poor quarter was 3 years ago. From there it went back up to $3.50 in 9 months.
Sorry, but it doesn't work that way. I suggest you read the U.S. Takeover Code.
"The buying company can make a tender offer on the open market. This must be a public declaration and there must be time for the market to absorb the news before the company can begin purchasing shares on the open market. The goal is to acquire 51% of the total shares in existence. "
BK 6 months out is total misinformation. NSPH has already an agreement in place that provides $30 million USD whenever they need it. That gives them more like 5 to 6 quarters of breathing room... at least.
NORTHBROOK, Ill., March 18, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced it has entered into a Common Stock Purchase Agreement with Aspire Capital Fund, LLC ("Aspire Capital"), whereby Nanosphere has the right to sell up to $30 million of shares of its common stock to Aspire Capital under certain conditions from time to time. Aspire Capital is an existing Nanosphere shareholder, having invested in the Company's most recent underwritten public offering in September 2013.
It's not about stock price, it's about getting 12%+ divi a year. People buy this for income. And...... they pay MONTHLY. Good luck to you with your short.
Not today dreamer. Maybe is someone comes out to say Samsung is not increasing production, or is only producing for internal usage. But not likely.
If Cramer was standing on the sidewalk soaking wet it would take him 2 hours to figure that it was raining.
He makes his stock calls based on what makes him and his buddies money. MU will be fine L/T.
Everything will be using solid state drives and flash memory in the future. Sandisk & Micron have bright futures in this area. Samsung is a player, but it is such a huge company it is not a pure play like the other two. MU will continue to go up this year and next even with a few media induced downturns along the way.
Someone is dumping big time. Does not mean the MU fundamentals or future is bad..... may just mean someone is taking the possible "correction" seriously and is profit taking.